Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes

<b>Background and aim</b>. Cancer and atrial fibrillation (AF) may be associated, and anticoagulation, either with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), is necessary to prevent thromboembolic events by reducing the risk of bleeding. The log incidence rate ra...

Full description

Bibliographic Details
Main Authors: Iris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, Gianmarco Parise, Linda Renata Micali, Giuseppe Musumeci, Mark La Meir, Furio Colivicchi, Michele Massimo Gulizia, Sandro Gelsomino
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
direct oral anticoagulants
warfarin
safety
efficacy
atrial fibrillation
cancer
Online Access:https://www.mdpi.com/2077-0383/11/19/5712

Internet

https://www.mdpi.com/2077-0383/11/19/5712

Similar Items